Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

<p style="text-align:justify;"> To improve strategies for the treatment of BRAF-mutant advanced colorectal cancer (aCRC) patients, we examined individual data from patients treated with chemotherapy alone in three randomised trials to identify points on the treatment pathway where o...

書目詳細資料
Main Authors:	Seligmann, JF, Fisher, D, Smith, CG, Richman, SD, Elliott, F, Brown, S, Adams, R, Maughan, T, Quirke, P, Cheadle, J, Seymour, M, Middleton, G
格式:	Journal article
語言:	English
出版:	Oxford University Press 2016

相似書籍

2530
由: Bernadette McKinney
出版: (2017-09-01)

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
由: Adams, R, et al.
出版: (2017)

BRAF and NRAS locus-specific variants have different outcomes on survival to colorectal cancer
由: Summers, MG, et al.
出版: (2016)

FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS and NRAS
由: Adams, R, et al.
出版: (2016)

Targeting mutant BRAF in colorectal cancer
由: Carroll David, et al.
出版: (2013-01-01)

Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
由: Seymour, M, et al.
出版: (2011)

The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer
由: Forsythe, N, et al.
出版: (2018)

Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing
由: Susan D. Richman, et al.
出版: (2011-01-01)

BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy
由: Vinay K. Pattalachinti, et al.
出版: (2025-02-01)

Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT
由: Louise C Brown, et al.
出版: (2022-12-01)

Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models
由: Federica Maione, et al.
出版: (2024-06-01)

Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.
由: Catherine E Bond, et al.
出版: (2012-01-01)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
由: Elisa Grassi, et al.
出版: (2021-06-01)

Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
由: Maughan, T, et al.
出版: (2009)

BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
由: Yasar Subutay Peker, et al.
出版: (2018-01-01)

DEFICIENT MISMATCH REPAIR (DMMR) AND BRAF MUTATION (MT) STATUS IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC): A META-ANALYSIS OF THE CAIRO, CAIRO2, COIN AND FOCUS STUDIES
由: Venderbosch, S, et al.
出版: (2012)

Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer - Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
由: Middleton, G, et al.
出版: (2011)

Pipeline electrical and instrumentation : switches and transmitters (CT25.30. and 31)
由: 599270 National Center for Construction Education and Research
出版: (2002)

Design of Collection Module of Underground Personnel Information Based on CC2530
由: ZHENG Mao-quan, et al.
出版: (2012-06-01)

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.
由: Seymour, M, et al.
出版: (2013)

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): A prospectively stratified randomised trial
由: Seymour, M, et al.
出版: (2013)

Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia
由: M. Yu. Fedyanin, et al.
出版: (2021-06-01)

Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors
由: Ting Xu, et al.
出版: (2022-06-01)

Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
由: Ting Xu, et al.
出版: (2023-05-01)

Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.
由: Smith, C, et al.
出版: (2013)

Design of Mine-used Wireless Roof Pressure Sensor Based on CC2530
由: WU Yao-ming, et al.
出版: (2012-12-01)

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
由: Maughan, T, et al.
出版: (2010)

RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer
由: Peipei Shang, et al.
出版: (2023-06-01)

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
由: Evelina Miele, et al.
出版: (2020-02-01)

Braf-Mutant Melanomas: Biology and Therapy
由: Elvira Pelosi, et al.
出版: (2024-12-01)

Dabrafenib for treatment of BRAF-mutant melanoma
由: Kainthla R, et al.
出版: (2013-12-01)

2530 Relationship between preexisting pain and completion of a community-based wellness program
由: Chantay Young, et al.
出版: (2018-06-01)

SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.
由: Ida V Lundberg, et al.
出版: (2014-01-01)

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer
由: Pan JH, et al.
出版: (2018-08-01)

Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancer
由: Rebecca Carter, et al.
出版: (2019-06-01)

THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
由: Maughan, T, et al.
出版: (2010)

Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.
由: Wood, G, et al.
出版: (2017)

Treatment with BRAF/MEK: inhibitors in mutant BRAF V600E papillary craniopharyngioma
由: Eva Marie Erfurth, et al.
出版: (2024-12-01)

Mutant-selective degradation by BRAF-targeting PROTACs
由: Shanique Alabi, et al.
出版: (2021-02-01)

Preoperative prediction of early recurrence in patients with BRAF mutant colorectal cancer using a intergrated nomogram
由: Zhenbin Jin, et al.
出版: (2024-10-01)